Purchase Order 12905B21P0228
- Not listed
- Bio-Rad Laboratories, Inc. was awarded a $21,000 firm fixed-price purchase order for a PCR CFX96 Real Time PCR Detection System by a civilian federal agency within the Pacific West Area on September 25, 2017, with an ultimate completion date of October 25, 2017. The award was made without small business set-aside designation to Bio-Rad's Life Science Group Division, with performance taking place at the contractor's facility in Hercules, California. This contract represents a single equipment...
- The U.S. government has awarded a firm-fixed-price purchase order worth $33,245.00 to Bio-Rad Laboratories, Inc.'s Life Science Group Division for a CFX CONNECT REAL-TIME PCR DETECTION SYSTEM. This contract has no set-aside designation and was awarded on August 18, 2021, with an ultimate completion date of October 31, 2021. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products, and this contract leverages the company's expertise in providing PCR...
- Bio-Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products, was awarded a firm fixed-price purchase order by the Pacific West Area civilian agency on August 3, 2018, for the CFX96 Touch Real-Time PCR Detection System. The contract, valued at approximately $20.2K, was completed by May 19, 2021, with performance conducted in Parlier, California. This procurement was made without a set-aside designation, reflecting Bio-Rad's status as a large business...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price purchase order valued at $21,713.65 by a civilian Northeast Area federal agency for a real-time quantitative polymerase chain reaction (qPCR) system and accessories. The award, based on quote number 19-Q22906V4 dated August 27, 2019, was issued on August 29, 2019, with an ultimate completion date of September 29, 2019. The equipment will be delivered to Hercules, California, where Bio-Rad is headquartered. No small business set-aside...
- Bio-Rad Laboratories Inc., a major supplier of life science research and clinical diagnostic products, was awarded a firm fixed price purchase order on August 3, 2018, for an annual service contract supporting a real-time polymerase chain reaction (PCR) operating system (serial 785BR15323). The contract, valued at $5,247, is scheduled for completion by August 2, 2019, and will be performed in Parlier, California. This unrestricted procurement received no small business set-aside designation...
- This is a firm fixed-price purchase order awarded by the Pacific West Area of the U.S. Department of Health and Human Services to Bio Rad Laboratories Inc. for a service agreement to maintain a CFX96 Real-Time PCR System. The contract, valued at $14,163.00, covers the period from September 15, 2020 to September 14, 2021, with a potential completion date of September 14, 2023. This award is not set aside for small businesses. Bio Rad Laboratories Inc. is a global manufacturer of life science...
- Bio-Rad Laboratories, Inc., through its Life Science Group Division, was awarded a $3,811 firm fixed-price purchase order by the Plains Area civilian federal agency for real-time polymerase chain reaction (PCR) service contract support. The contract was issued on February 15, 2017, with an ultimate completion date of December 23, 2017, and does not carry a small business set-aside designation. Performance is specified for Manhattan, Kansas, where Bio-Rad will deliver real-time PCR services and...
- Bio-Rad Laboratories Inc. received a firm fixed-price purchase order from the Pacific West Area, a civilian agency, for field service travel to repair a CFX96 optical module and thermal cycler C1000 instrument. The contract, awarded on June 29, 2018, carries a ceiling value of $4,100 and was completed by May 16, 2019. The work was performed in Parlier, California, with no small business set-aside applied to this unrestricted procurement. This repair and maintenance service falls within Bio-Rad's...
- Bio-Rad Laboratories Inc., headquartered in Hercules, California, was awarded a purchase order contract valued at $24,845 by a civilian federal agency (Northeast Area) on September 17, 2019, with an ultimate completion date of October 28, 2019. The contract involves the delivery of a CFX384 Optical Reaction Module—a 384-well optical module for real-time polymerase chain reaction (PCR) applications that includes CFX Manager software and cables for use with a C1000 cycler chassis. This is a firm...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price purchase order valued at $3,811.00 by a civilian federal agency (Northeast Area) for a one-year comprehensive support plan covering a real-time polymerase chain reaction (PCR) system. The contract, awarded on August 17, 2015, with an ultimate completion date of August 22, 2016, includes unlimited repair services encompassing travel, parts, and labor. The scope encompasses a thermal cycler and optical reaction module, with exclusions for...
Bio-Rad Laboratories Inc. received a $15,000 firm fixed-price purchase order from a Pacific West Area civilian federal agency for CFX Connect real-time polymerase chain reaction (PCR) detection equipment. The award, issued on August 5, 2021, with an ultimate completion date of September 5, 2021, represents a non-set-aside procurement of specialized laboratory instrumentation. The place of performance is Parlier, California, where the vendor will fulfill delivery of the PCR detection system. As a subsidiary of Bio-Rad Laboratories, Inc., the awardee is an established supplier of life science research and clinical diagnostic products to federal agencies including the Department of Veterans Affairs, Defense Health Agency, Centers for Disease Control and Prevention, and the Department of the Army. Bio-Rad Laboratories operates multiple significant federal contract vehicles, including a $13.77 million Indefinite Delivery Contract with the Defense Health Agency for serological automated analyzers and a $2.29 million Blanket Purchase Agreement with the Department of the Air Force for Bio-Plex diagnostic analyzers and related reagents. This purchase order aligns with the vendor's core business of providing advanced PCR systems and diagnostic technologies to support federal research, healthcare, and medical readiness operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($150) | 11/15/22 | |
| Not listed | Not listed | $15.2k | 8/5/21 |